Search

everythinglearnresearchcommunity

for

Search:↓

The compounds tested could potentially treat hair loss and alopecia.

Sebocytes play a key role in controlling androgen levels in human skin.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Compound 15a was effective in inhibiting 5α-reductase.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

A new compound effectively inhibits human 5α-reductase 1.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

A new gene, JMJD1C, may affect testosterone levels in men.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.